Development and in vitro/in vivo evaluation of a triply periodic minimal surface-based 3D-printed anti-infective bone scaffold with spatiotemporally controlled osteogenesis
Abstract
Infectious bone defects (IBDs), marked by the concurrent presence and progressive aggravation of both bone infection and bone loss, represent a significant clinical challenge. Traditional staged treatment, namely initial infection control followed by bone reconstruction, often involves multiple surgeries, extended treatment durations, and high costs. Herein, we developed a novel 3D-printed titanium alloy scaffold for IBDs, integrating spatiotemporally controlled dual-drug delivery. The scaffold features a triply periodic minimal surface structure with a radial pore gradient, increasing from the core to the periphery. The inner layer with smaller pores is loaded with bone morphogenetic protein-2 (BMP-2), whereas the outer layer with larger pores incorporates RM-PLGA microspheres for the sustained release of rifampicin and moxifloxacin. The gelatin methacryloyl (GelMA) hydrogel serves as the coating matrix for drug immobilization. This design enables a sequential therapeutic strategy, initial sustained antibacterial activity, followed by osteoinductive stimulation, facilitating a dynamic repair process from early infection control to later-stage bone regeneration. In vitro assays confirmed that the RM-PLGA/BMP-2 (GelMA)@TiS scaffold exhibits potent antibacterial activity, cytocompatibility, osteogenic potential, and extracellular matrix mineralization. In vivo results further demonstrated its efficacy in suppressing Staphylococcus aureus infection while promoting bone…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.